HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms.
During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities:
• Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX.
• HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth.
Mr. Albert Wong, CEO of HKSTP, said: 'We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.'
Ahead of BIO 2025, the delegation participated in the '2025 Biomedical Pitch Competition', co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth.
HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as 'Edison of Medicine'), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader.
Appendix: List of Park Companies Participating in BIO 2025:
1. Allegrow Biotech Limited
2. ARBELE Limited
3. Beth Bioinformatics Co., Limited
4. Centre for Translational Stem Cell Biology
5. The Centre for Virology, Vaccinology, and Therapeutics
6. DECODE CURE Limited
7. GenEditBio Limited
8. Great Bay Bio
9. Hong Kong Universal Biologicals Company Limited
10. Immuno Cure Holding (HK) Limited
11. The Institute for Innovation, Translation and Policy Research (ITPR)
12. LEE'S PHARMACEUTICAL (HK) LIMITED
13. Serilink Biotechnology Company Limited
14. Xiaomo Biotech Limited
15. XUXIN (HongKong) Biotechnology Co., Limited
16. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
Hashtag: #HKSTP
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
a day ago
- The Sun
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the 'Group')grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the 'drug, medical device and Aesthetics' field. 1、 High-end medical aesthetics: GeneQueens series At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition. GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin. In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an 'instant enjoyment' precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot. 2、金因敷 showcased a variety of new products Meanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics. 金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care. 3、The latest research data was presented at CSD2025 It is worth mentioning that 肌顏態® also showcased the research data of 'The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure' jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products. As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice. 4、Academic speeches by several experts Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®' s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing. In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time. Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends 6、The signing ceremony reflects the market potential Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: ' We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the 'Drugs, Medical device and Aesthetics' strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. ' Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as '皮優理'. The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value. The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the 'Drugs, Medical device and Aesthetics' strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.
The Sun
a day ago
- The Sun
Trend Micro Named a Leader in IDC MarketScape for CNAPP
HONG KONG SAR - Media OutReach Newswire - 2 July 2025 - Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced it has been named as a Leader in the IDC MarketScape for Worldwide Cloud-Native Application Protection Platforms (CNAPP) 2025 Vendor Assessment (doc #US53549925, June 2025). To read the IDC MarketScape: Worldwide Cloud-Native Application Protection Platform (CNAPP) 2025 Vendor Assessment excerpt, please visit: Rachel Jin, Chief Enterprise Platform Officer at Trend: 'For as long as our customers have been leveraging the cloud for strategic advantage, we've offered comprehensive protection for their hybrid environments. Those two decades of experience show in these results. Customers value our cloud security capabilities and effective risk management across the entire attack surface. Security is a true business enabler.' The CNAPP category has evolved and expanded over the years to include everything from anti-malware and application control to configuration management, app developer tools, and coverage of virtualized datacenters alongside cloud-native apps/workloads. Trend Vision One™ Cloud Security pushes the boundaries even further by offering enterprise customers AI-powered threat prediction, protection and response—including continuous monitoring to enhance exposure management and resilience as well as streamlined incident response. Trend offers flexible licensing that enables customers to increase or decrease their workloads dynamically. This approach ensures that customers only pay for what they use, making it a cost-effective solution that can adapt to changing business needs. Trend Micro was positioned in the Leaders Category alongside four other worldwide vendors out of a total of 13, evaluated according to current capabilities and 3-5-year strategy, and how well these align with customer needs. Key benefits of Trend Vision One™ Cloud Security include: • A comprehensive range of capabilities including cloud risk management, extended detection and response (XDR), server and workload security, container security, file security, and code security • Agentless capabilities for streamlined deployment/coverage • Strong industry partnership with major cloud players (AWS/Google/Azure/GCP etc) to maintain a cutting-edge advantage • Continuous, proactive monitoring of security posture, managed via a centralized dashboard • Zero trust architecture • Backing from a global network of 500 researchers, analysts and data scientists, and a Zero Day Initiative community of 18,000 external threat researchers According to the IDC MarketScape: 'The Trend Vision One™ CNAPP offers multilayered security by centralizing findings and cross-correlating data from various layers, powered by AI, ensuring robust protection against complex attacks. Features like holistic threat detection, risk assessment, and a flexible pay-as-you-go (PAYGO) billing mechanism provide a cost-effective solution that adapts to changing business needs.'
The Sun
a day ago
- The Sun
Chilli Manis: From Zero to Singapore's 4.8-Star Caterer in 7 Years
SINGAPORE - Media OutReach Newswire - 2 July 2025 - In just seven years, Chilli Manis has grown from humble beginnings to become one of Singapore's best-rated food caterers. Their swift ascent—marked by industry accolades and glowing customer reviews—is powered by a unique blend of Peranakan heritage, unshakable resilience, and a simple yet profound mantra: 'Love Your Guests, Serve the Best.' A Dream Built on Grit, Faith & Peranakan Heart Launched in 2018 as a niche Peranakan catering concept, Chilli Manis was a bold experiment within its investor group. Managing Director Benjamin Seow, inspired by his mother, Madam Serene Hoh's decades of Nyonya culinary wisdom, became the driving force behind the brand's vision. 'We started from absolute zero,' Benjamin shares. 'Everything—from menus to props—was built in-house. With no clients or reputation, morale was low. Every order felt like a miracle.' After a grueling first year, signs of progress began to show—only for COVID-19 to bring everything to a halt. 'Our growing momentum vanished overnight,' Benjamin recalls. 'But we saw it as a chance to focus on what truly mattered.' With events on pause, the team turned inward. Every member—from chefs to delivery staff—underwent training in what would become their non-negotiable standard: True Peranakan hospitality goes beyond food—it's about warmth, care, and treating every guest like family. 'When the industry rebounded, we weren't just ready with recipes—we were ready with heart,' Benjamin adds. Celebrating SG60 with Chilli Manis In celebration of this milestone and Singapore's 60th National Day (SG60), Chilli Manis Catering is offering two heartfelt promotions: • $60 Off First Order. Enjoy $60 off your first order with promo code MANISSG60 (Min. $600 menu spend, valid for Full or Mini Buffet orders). Valid until 21 August 2025. • National Day Baby Giveaway • Six eligible individuals born on 9 August will be gifted a buffet worth $660. • To participate, those born on: • 9 August 1965, 9 August 2025, or 9 August (any year) • Follow @chillimanis on Instagram and send a DM with their birthdate. • Campaign Period: 16 June – 17 August 2025, 11:59 PM. • For full details, visit @chillimanis on Instagram. These run from 16 June to 17 August 2025. For full details and terms, refer to @chillimanis' post on Instagram. What Makes Us 'Best' - The People Who Believe in Us What defines the best food caterer? For some, it's recognition. For others, it's the memories created around a shared meal. At Chilli Manis, it's both—and more. In 2024, Chilli Manis was honoured as Singapore's Most Popular Promising Brand at the Singapore Prestige Brand Awards (SPBA)—a milestone that reflects their deep respect for tradition, keen eye for detail, and unwavering commitment to innovation. They are also Singapore's highest-rated caterer on Google, with a 4.8-star rating from over 1,300 reviews. Customers often praise the brand's authentic Peranakan flavours, elegant presentation, and a hospitality that feels like home. 'We began with a modest kitchen and big dreams,' Benjamin reflects. 'Today, we're living proof that when you pour heart into every dish and care into every event, success follows naturally. But our greatest reward isn't the awards—it's seeing first-time customers become regulars, and regulars become like family.' Visit the website for full menus, bookings, and more on its comprehensive offerings — including popular halal catering buffet Singapore options, extensive Peranakan food catering, and specialised dessert tables.
